La radioterapia stereotassica per il trattamento delle metastasi vertebrali: nuove frontiere ed evidenze a supporto
Registrati Qui Le metastasi vertebrali rappresentano un fenomeno di frequente riscontro nei pazienti oncologici con un impatto significativo sulla qualità della vita per il loro carico sintomatologico e il rischio fratture. Per molti anni, la radioterapia convenzionale ha rappresentato la prima scelta in pazienti con metastasi vertebrali, pur producendo risposte sub-ottimali e limitate nel tempo. […]
Accuray Exchange Showcase: Conference Highlights from 2025
Join us for the second annual Accuray Exchange Showcase: Conference Highlights from 2025, your opportunity to explore the impactful research and innovations using the CyberKnife® and Radixact® Systems, presented at leading global conferences, including ESTRO, RSS, ISRS, AAPM and ASTRO.
Transforming Palliative Radiation Therapy: The Role and Impact of the Advanced Practice Radiation Therapist in the U.S.
Join our RTT webinar to learn about efforts to bring advanced practice RTs to the US and the advantages to practice they bring.
Breast Radiotherapy in 2025: Integrating Landmark Trials and Technological Advances
Join us for an insightful presentation exploring the latest, practice-changing clinical trials that are reshaping the standards of care in breast cancer radiotherapy.
RADIOSA Trial and Beyond: Exploring the Full Potential of SBRT in Advanced Prostate Cancer
In this presentation, the presenters will discuss the design, outcomes, and clinical implications of the phase II RADIOSA trial, which evaluated stereotactic body radiotherapy (SBRT) alone versus SBRT combined with short-course androgen deprivation therapy (ADT) in patients with hormone-sensitive oligo-recurrent prostate cancer.
Mise en place de la nouvelle décision ANSM pour les systèmes TomoTherapy® et Radixact®
Le CHU de Saint-Quentin et le Centre Oscar Lambret partageront en détail leurs programmes de contrôle qualité pour les systèmes TomoTherapy® et Radixact®, mis en œuvre suite à la nouvelle décision de l’ANSM.
CMS Proposed Rules and ROCR Updates
Join us for an informative and interactive webinar exploring the latest proposed regulations from the Centers for Medicare & Medicaid Services (CMS) and their implications for the field of Radiation Oncology.
Local Ablation in the Management of Primary and Metastatic Gynecologic Cancers: A Review of Evidence and Indications for Stereotactic Body Radiotherapy (SBRT)
Join us for this informative review of the current evidence in SBRT for Gynecologic Cancers.
Moderate and Extreme Hypofractionation for Locally Advanced Non-Small Cell Lung Cancer
In this webinar, we will explore the available literature data reporting the outcomes of moderate hypofractionation and extreme hypofractionation applied in the setting of locally advanced non-small cell lung cancer.
University Hospital Birmingham’s experience using PreciseArt® and structure reports for Radiotherapy Head and Neck patients
View Recording Join us for an insightful webinar on leveraging PreciseART® and automated reporting to enhance treatment workflows for head and neck patients. We’ll share our experience using these tools to standardise processes, improve workflow efficiency and enhance treatment precision. Presenters: Sallie Melsom, Technical Lead Radiographer, University Hospital Birmingham (UHB) NHS Foundation Trust, Birmingham, UK Sallie Melsom is […]